PWM
MGNX icon

Perigon Wealth Management’s MacroGenics MGNX Stock Holding History

Perigon Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$3K – 471
2018
Q1 		$3K Hold
100
– – ﹤0.01% 582
2017
Q4 		$2K Hold
100
– – ﹤0.01% 573
2017
Q3 		$2K Buy
+100
New +$1.73K ﹤0.01% 603

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Perigon Wealth Management's MGNX Position: Q2 2018 in Review

Perigon Wealth Management sold out of MacroGenics (MGNX) in Q2 2018, closing a stake of 100 shares — an estimated $3K sold.

Perigon Wealth Management first reported a position in MGNX in Q3 2017 and held it in 3 quarters. The position peaked at $3K in Q1 2018. 127 funds tracked by Wall St. Rank hold MGNX as of Q2 2018.

  • Perigon Wealth Management reported no remaining MacroGenics position as of Q2 2018 after selling out during the quarter.
  • Perigon Wealth Management sold 100 MacroGenics shares in Q2 2018, an estimated $3K.
  • Perigon Wealth Management first reported a position in MacroGenics in Q3 2017 and held it in 3 quarters.
  • Perigon Wealth Management's MacroGenics position peaked at $3K in Q1 2018.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q2 2018.

Based on Perigon Wealth Management's 13F filing for Q2 2018, filed 7 Aug 2018.